Diopter Technologies has reached a significant milestone in the development of a groundbreaking treatment for ocular surface diseases, including dry eye syndrome, corneal trauma injuries, and post-surgical wounds. The company announced the completion of early clinical studies for its dissolving amniotic membrane and biopolymer contact lens, a therapeutic device that represents a leap forward in eye care technology.
The innovative lens is designed to release growth factors from amniotic-derived materials while dissolving over 48-72 hours, eliminating the need for clinical removal. This feature not only enhances patient comfort but also reduces the risk of disrupting healing tissues during lens removal. The device's sustained growth factor release mechanism has been shown to reduce scarring and inflammation while promoting epithelial regeneration, offering a dual-action approach to ocular surface rehabilitation.
Initial clinical study results are promising, with no adverse events reported and increased patient comfort observed over the continuous wear period compared to standard silicon hydrogel lenses. Diopter Technologies' CEO, Chris Adams, emphasized the device's ability to actively deliver healing factors, marking a shift from passive protection to intelligent tissue remodeling.
The potential applications of this technology are vast, with ongoing clinical studies exploring its efficacy in chemical/thermal injury recovery, post-refractive surgery care, and chronic dry eye management. With plans to launch the product in Q1 2026, pending FDA approval, Diopter Technologies is poised to address significant market opportunities in ocular surface disease treatment.
This development underscores the company's commitment to merging advanced materials science with clinical ophthalmology, further solidifying its position as a pioneer in ocular therapeutic delivery systems. The dissolving amniotic membrane biopolymer contact lens could revolutionize the treatment of ocular surface diseases, offering patients a safer, more effective, and convenient option for eye care.
